Daniel Strauss

Daniel Strauss has worked in a variety of business development roles since 2017. Daniel began their career at Biological Industries as a Business Development Consultant, followed by a role as a Business Development Consultant at Nanovibronix (NASDAQ:NAOV). In 2018, they worked as a Business Development Consultant at BRH MEDICAL LIMITED and Sanolla. In 2019, they were a Business Development Consultant at NovaSight, and in 2021, they took on a Business Development Consultant role at DUSMIT. Currently, they are a Business Development Consultant at Cherry Imaging.

Daniel Strauss attended New York University from 1997 to 1999, where they obtained a Bachelor of Science degree.